The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,411,707 in first-year total cost, median $705,854.
Most frequent study sections
- Special Emphasis Panel[ZAI1 SAG-A (M2)]2
Most frequent institutions
- UNIVERSITY OF FLORIDA1
- UNIVERSITY OF MELBOURNE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Therapeutic Disruption of HIV Transcription by HIV-1 Tat Protein-Degrading Molecules1R01AI194820-01 | VALENTE, SUSANA T | UNIVERSITY OF FLORIDA, FL | $1,016,887 | ZAI1 |
| 2025 | Direct and Indirect Targeting of HIV Tat for Selective RNA Degradation and Protein Suppression1R01AI194343-01 | TELWATTE, SUSHAMA | UNIVERSITY OF MELBOURNE | $394,820 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.